Featured Science from Thursday, Feb. 23
Thursday Main Event
11:00 a.m. to 12:00 p.m. - Hall C
Late-Breaking Science Oral Abstracts I
1:30 p.m. to 3:00 p.m. - Grand Ballroom B
The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Steven R. Lentz, MD, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology
The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.
Ileana L. Piña, MD, MPH, FAHA, FACC
Chair, Council on Clinical Cardiology
The mission of the American Heart Association (AHA) Council on Functional Genomics and Translational Biology (FGTB) is to advance discoveries from genetics, systems and translational biology and to facilitate their application in global cardiovascular health and disease.
Svati Shah, MD, MS, MHS, FAHA
Chair, Council on Functional Genomics and Translational Biology